Physician profile
Christopher Brian Marchack
NPI 1710146469
$88,028.63
in general payments reported to CMS, 2019-2025
10 companies · $19K in 2025
The $19K reported for 2025 was more than what 96% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $12K · 2023: $13K · 2024: $20K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,819 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,189.90 |
| Travel and Lodging | $15,696.40 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,818.90 |
| Food and Beverage | $196.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $48,895.65 | 2019-2023 | Education, Nobelactive |
| Envista Holdings Corporation | $38,886.30 | 2024-2025 | Education |
| 3m Company | $51.82 | 2019 | |
| Solventum Corporation | $48.04 | 2025 | Clarity Aligners |
| Dentsply Sirona INC | $46.87 | 2023-2025 | Suresmile |
| Geistlich Pharma, North America, INC. | $33.10 | 2023 | Bio-Gide |
| Align Technology, INC. | $21.55 | 2025 | Invisalign |
| Straumann USA LLC | $16.42 | 2019 | |
| Ultradent Products INC | $16.36 | 2019 | |
| Carestream Dental, LLC | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Marchack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.